AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Marketing.
In this role Gibb will be responsible for building and leading the sales organisation and strengthening the company's commercial presence.
Gibb has more than 20 years of global sales leadership experience. He has worked as VP of Sales and Marketing at Nortis Biosciences, VP of Global Sales at Araceli Biosciences, VP of Global Sales at Emulate, and held senior sales roles at Thermo Fisher Scientific and Becton Dickinson & Co.
Alif Saleh, AxoSim CEO, said: "We are excited to welcome Stuart as a key member of our team. He has an impressive track record in commercialising and scaling organ-on-a-chip platforms from zero to multi-million-dollar businesses."
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head